148 related articles for article (PubMed ID: 9523322)
1. Efficacy and pharmacokinetics of site-specific cefazolin delivery using biodegradable implants in the prevention of post-operative wound infections.
Allababidi S; Shah JC
Pharm Res; 1998 Feb; 15(2):325-33. PubMed ID: 9523322
[TBL] [Abstract][Full Text] [Related]
2. Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections.
Chilukuri DM; Shah JC
Pharm Res; 2005 Apr; 22(4):563-72. PubMed ID: 15846464
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and mechanism of release from glyceryl monostearate-based implants: evaluation of release in a gel simulating in vivo implantation.
Allababidi S; Shah JC
J Pharm Sci; 1998 Jun; 87(6):738-44. PubMed ID: 9607952
[TBL] [Abstract][Full Text] [Related]
4. Continuous infusion of cefazolin is superior to intermittent dosing in decreasing infection after hemorrhagic shock.
Livingston DH; Wang MT
Am J Surg; 1993 Feb; 165(2):203-7. PubMed ID: 8427396
[TBL] [Abstract][Full Text] [Related]
5. Better prophylaxis against surgical site infection with local as well as systemic antibiotics. An in vivo study.
Cavanaugh DL; Berry J; Yarboro SR; Dahners LE
J Bone Joint Surg Am; 2009 Aug; 91(8):1907-12. PubMed ID: 19651948
[TBL] [Abstract][Full Text] [Related]
6. Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats.
Fallon MT; Shafer W; Jacob E
J Surg Res; 1999 Sep; 86(1):97-102. PubMed ID: 10452874
[TBL] [Abstract][Full Text] [Related]
7. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Atahan E; Gul M; Ergun Y; Eroglu E
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
[TBL] [Abstract][Full Text] [Related]
8. Tobramycin-containing bone cement and systemic cefazolin in a one-stage revision. Treatment of infection in a rabbit model.
Nijhof MW; Fleer A; Hardus K; Vogely HC; Schouls LM; Verbout AJ; Dhert WJ
J Biomed Mater Res; 2001; 58(6):747-53. PubMed ID: 11745530
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic embedded absorbable prosthesis for prevention of surgical mesh infection: experimental study in rats.
Suárez-Grau JM; Morales-Conde S; González Galán V; Martín Cartes JA; Docobo Durantez F; Padillo Ruiz FJ
Hernia; 2015 Apr; 19(2):187-94. PubMed ID: 25519076
[TBL] [Abstract][Full Text] [Related]
10. Combined use of topical and systemic antibiotics.
Scher KS; Peoples JB
Am J Surg; 1991 Apr; 161(4):422-5. PubMed ID: 2035760
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release.
Park ES; Maniar M; Shah JC
J Control Release; 1998 Mar; 52(1-2):179-89. PubMed ID: 9685948
[TBL] [Abstract][Full Text] [Related]
12. beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses.
Fields MT; Herndon BL; Bamberger DM
Antimicrob Agents Chemother; 1993 Feb; 37(2):203-6. PubMed ID: 8452349
[TBL] [Abstract][Full Text] [Related]
13. A comparison of topical and systemic cefazolin for wound prophylaxis.
Scher KS; Jones CW; Wroczynski AF
Surg Gynecol Obstet; 1984 Feb; 158(2):117-9. PubMed ID: 6364425
[TBL] [Abstract][Full Text] [Related]
14. Cefuroxime versus cefazolin as prophylaxis in vascular surgery.
Edwards WH; Kaiser AB; Kernodle DS; Appleby TC; Edwards WH; Martin RS; Mulherin JL; Wood CA
J Vasc Surg; 1992 Jan; 15(1):35-41; discussion 41-2. PubMed ID: 1728688
[TBL] [Abstract][Full Text] [Related]
15. Low-inoculum model of surgical wound infection.
Kaiser AB; Kernodle DS; Parker RA
J Infect Dis; 1992 Aug; 166(2):393-9. PubMed ID: 1634811
[TBL] [Abstract][Full Text] [Related]
16. Acellular dermal matrix compared with synthetic implant material for repair of ventral hernia in the setting of peri-operative Staphylococcus aureus implant contamination: a rabbit model.
Milburn ML; Holton LH; Chung TL; Li EN; Bochicchio GV; Goldberg NH; Silverman RP
Surg Infect (Larchmt); 2008 Aug; 9(4):433-42. PubMed ID: 18759680
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin.
Mauerhan DR; Nelson CL; Smith DL; Fitzgerald RH; Slama TG; Petty RW; Jones RE; Evans RP
J Bone Joint Surg Am; 1994 Jan; 76(1):39-45. PubMed ID: 8288664
[TBL] [Abstract][Full Text] [Related]
18. Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model.
Nijhof MW; Stallmann HP; Vogely HC; Fleer A; Schouls LM; Dhert WJ; Verbout AJ
J Biomed Mater Res; 2000 Dec; 52(4):709-15. PubMed ID: 11033554
[TBL] [Abstract][Full Text] [Related]
19. Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.
Chen X; Brathwaite CE; Barkan A; Hall K; Chu G; Cherasard P; Wang S; Nicolau DP; Islam S; Cunha BA
Obes Surg; 2017 Mar; 27(3):626-629. PubMed ID: 27520693
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefazolin for prophylactic administration to dogs.
Gonzalez OJ; Renberg WC; Roush JK; KuKanich B; Warner M
Am J Vet Res; 2017 Jun; 78(6):695-701. PubMed ID: 28541147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
